| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
When interference is suspected, the measurement should be repeated after dilution, and/or assessed by an immunoassay of different origin using different antibodies.
The first case concerned a patient who was moderately suspected of thyroid disease (normal free T4 level of 17.1 pmol/L and elevated TSH 118 mIU/L, Roche Modular, normal values 1.5–3.5 mIU/L). The TSH diluted in a linear fashion up to 20 times. The measurement was repeated in another laboratory giving TSH 25.2 mIU/L (Abbott Architect, normal values 0.4–4.0 mIU/L) but on this occasion abnormal dilution behaviour was noted. After removal of IgG by Protein G affinity chromatography, as described previously,3 a TSH of 2.7 mIU/L was found. The sample was distributed to other laboratories who tested for TSH with five further assay methods different from the previous two. In all cases spuriously elevated TSH values of variable apparent concentrations were found which seemed unrelated to the assay format (Table 1). It must be noted that some of the between-method differences were too small to raise suspicion. Dilution tests also gave variable results. Where tested (Perkin-Elmer DELFIA), dilution in mouse serum did not improve dilution behaviour, the use of Scantibodies Blocking tubes was ineffective.
|
We conclude that interference by heterophilic antibodies may escape detection if not extensively evaluated. Neither a normal dilution test nor similar results by two different assay methods exclude the presence of interference. Furthermore, screening for only IgG antibodies may give a false negative result, since interference can be due to IgM-antibodies as well. As interferences in TSH-assays are rare,4 the above-mentioned cases show the importance of good communication between clinics and laboratories.
1 Department of Chemical Endocrinology, Radboud University, Nijmegen Medical Centre, Nijmegen;
2 Department of Clinical Chemistry, University Hospital Maastricht, Maastricht;
3 Department of Internal Medicine, Slingeland Hospital, Doetinchem;
4 Department of Endocrinology, University Medical Centre Groningen and University of Groningen, Groningen, The Netherlands
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A A A Ismail Interference from endogenous antibodies in automated immunoassays: what laboratorians need to know J. Clin. Pathol., August 1, 2009; 62(8): 673 - 678. [Abstract] [Full Text] [PDF] |
||||
![]() |
D J Halsall, E English, and V K Chatterjee Interference from heterophilic antibodies in TSH assays Ann Clin Biochem, July 1, 2009; 46(4): 345 - 346. [Full Text] [PDF] |
||||
![]() |
A. C Heijboer, R. G Ijzerman, A. A Bouman, and M. A Blankenstein Two cases of antiruthenium antibody interference in Modular free thyroxine assay Ann Clin Biochem, May 1, 2009; 46(3): 263 - 264. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||